Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation
- 1 October 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 311 (1) , 1-7
- https://doi.org/10.1124/jpet.104.070961
Abstract
Methamphetamine intoxication causes long-lasting damage to dopamine nerve endings in the striatum. The mechanisms underlying this neurotoxicity are not known but oxidative stress has been implicated. Microglia are the major antigen-presenting cells in brain and when activated, they secrete an array of factors that cause neuronal damage. Surprisingly, very little work has been directed at the study of microglial activation as part of the methamphetamine neurotoxic cascade. We report here that methamphetamine activates microglia in a dose-related manner and along a time course that is coincident with dopamine nerve ending damage. Prevention of methamphetamine toxicity by maintaining treated mice at low ambient temperature prevents drug-induced microglial activation. MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), which damages dopamine nerve endings and cell bodies, causes extensive microglial activation in striatum as well as in the substantia nigra. In contrast, methamphetamine causes neither microglial activation in the substantia nigra nor dopamine cell body damage. Dopamine transporter antagonists (cocaine, WIN 35,428 [(–)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane 1,5-naphthalenedisulfonate], and nomifensine), selective D1 (SKF 82958 [(±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide]), D2 (quinpirole), or mixed D1/D2 receptor agonists (apomorphine) do not mimic the effect of methamphetamine on microglia. Hyperthermia, a prominent and dangerous clinical response to methamphetamine intoxication, was also ruled out as the cause of microglial activation. Together, these data suggest that microglial activation represents an early step in methamphetamine-induced neurotoxicity. Other neurochemical effects resulting from methamphetamine-induced overflow of DA into the synapse, but which are not neurotoxic, do not play a role in this response.This publication has 43 references indexed in Scilit:
- Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated MechanismJournal of Neuroscience, 2004
- Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicityExperimental Neurology, 2004
- Parkinson's DiseaseNeuron, 2003
- Productive HIV-2 infection in the brain is restricted to macrophages/microgliaAIDS, 2003
- Microglia as a source and target of cytokinesGlia, 2002
- Microglia as neuroprotective, immunocompetent cells of the CNSGlia, 2002
- Beyond Phrenology: What Can Neuroimaging Tell Us About Distributed Circuitry?Annual Review of Neuroscience, 2002
- Microglia in neurodegeneration: Molecular aspectsMicroscopy Research and Technique, 2001
- Microglia: a sensor for pathological events in the CNSTrends in Neurosciences, 1996
- MK-801 prevents microglial reaction in rat hippocampus after forebrain ischemiaNeuroReport, 1992